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TO THE EDITOR
The inhibition of unwanted hair growth
(hirsutism, hypertrichosis) by safe and
effective agents that do not destroy the
hair follicle (HF) remains an important
challenge in clinical dermatology. Being
interested in identifying alternative
therapies to depilation, laser therapy,
anti-androgens, and eflornithine (Blume-
Peytavi, 2013), we explored whether
modulating peroxisome proliferator–
activated receptor-g (PPARg) may inhibit
human hair growth.
PPAR activation controls the expression
of genes that regulate inflammation and
lipid metabolism and exerts strong anti-
inflammatory effects (Choi and Bothwell,
2012, Supplementary References S7 and
S12 online). Moreover, PPARg activation
stimulates keratinocyte and sebocyte
differentiation and also epidermal lipid
synthesis and regulates the epidermal
barrier homeostasis (Supplementary
Figures S3 and S10 online). PPARg
signaling is also required for the main-
tenance of HF epithelial stem cells in
mice, although insufficient PPARg
signaling may predispose patients to
develop the inflammatory cicatricial
alopecia, lichen planopilaris (LPP;
Karnik et al., 2009; Harries et al., 2013).
Recently, interest has grown in devel-
oping selective PPARg modulators that
retain the desirable therapeutic activities
without the unwanted effects of classical
agonists (Higgins and Depaoli, 2010).
Therefore, we tested a newly designed
anti-inflammatory PPARg modulator,
GMG-43AC, a chemical entity with
structural similarity to propionic acid,
with a favorable toxicological profile
(Pirat et al., 2012). GMG-43AC func-
tions as a selective PPARg modulator
(see Supplementary Text and Supple-
mentary Figure S1a–c online).
GMG-43AC was administered to micro-
dissected, organ-cultured HFs from a
female patient’s scalp, obtained after
written informed consent and with the
University of Luebeck ethics approval
(Kloepper et al., 2010). Its potential anti-
inflammatory effects were assessed in
normal human keratinocytes (NHKs) ex-
posed to defined inflammatory stimuli.
Lactate dehydrogenase (LDH) levels
in the HF organ culture supernatants
showed only a slight increase by day 6
(Supplementary Figure S2a online), sug-
gesting only low-level GMG-43AC-
associated general tissue toxicity.
Although the administration of GMG-
43AC for 6 days did not alter hair shaft
elongation (Supplementary Figure S2b
online), HF cycle analyses revealed that
all tested GMG-43AC doses strongly
decreased the percentage of HFs in
anagen, and induced premature HF
regression (catagen; Figure 1a): although
only 55% of the HFs treated with vehi-
cle transformed into the catagen phase
after 6 days, almost all (85%) of the
0.01 mM GMG-43AC-treated HFs were
in this phase. In the two higher doses of
GMG-43AC, 70% of HFs were in the
catagen phase. These results were inde-
pendently confirmed by measuring the
hair cycle score (s2), which reached
significance in the 0.01 mM dose
(Figure 1b), supporting the hypothesis
that GMG-43AC promotes catagen.
Although GMG-43AC did not signifi-
cantly alter the percentage of proliferat-
ing hair matrix keratinocytes in anagen
VI HFs, it tended to stimulate
keratinocyte apoptosis in the hair matrix
(significance reached at 0.1 mM; Supple-
mentary Figure S2c online).
Next, we explored whether GMG-
43AC modulates the expression of two
signature keratins expressed by human
HF progenitor cells, namely, keratins K15
and K19 (Lyle et al., 1998; Kloepper
et al., 2008, Supplementary References
S6 and S8 online). Interestingly, GMG-
43AC significantly upregulated K15
immunoreactivity in all tested doses
in situ (Figure 1c) but did not significantly
alter the number of K15-positive cells
(Figure 1c). A positive impact on human
HF epithelial progenitor cells was inde-
pendently corroborated by demonstrating
that K19 immunoreactivity was also sig-
nificantly upregulated by GMG-43AC;
moreover, the number of K19-positive
cells in the lower outer root sheath was
increased (Figure 1d). Thus, GMG-43AC
may effectively inhibit unwanted human
hair growth by inducing catagen while
simultaneously preserving (or possibly
even promoting) the HF’s epithelial pro-
genitor cell pools.
As a first attempt toward identifying
early-response candidate target genes of
GMG-43AC-mediated stimulation, two
independent sets of organ-cultured HFs
from a female patient’s scalp were com-
pared by genome-wide DNA microarray
analysis (see Supplementary Text online).
This identified 39 candidate early-
response genes as being substantially
upregulated (i.e., 43 fold, Po0.05) in
the HFs of both patients investigated by
stimulation with 0.01 mM GMG-43AC
for 6 hours (Supplementary Table S1
online). Among these upregulated genes,
none was a gene recognized to be
specific for epithelial HF stem cells.
However, COL6A1, which encodes the
alpha 1 chain of collagen VI, is known
to be expressed in very close proximity
to the HF (Watson et al., 2001) and
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may be involved in HF development
(Smith, 1994). Quantitative reverse
transcriptase–PCR independently con-
firmed that GMG-43AC significantly
increased COL6A1 mRNA expression
(Supplementary Figure S2d online; for
extended discussion, see legend of
Supplementary Table S1 online).
As PPARg activation elicits anti-
inflammatory responses (Choi and
Bothwell, 2012), we finally investigated
the effect of GMG-43AC on mRNA
expression and protein secretion of IL-6
in NHKs treated with IFN-g or tumor
necrosis factor (TNF)-a. As expected,
treatment of NHKs with IFN-g
(30ngml1) or TNF-a (10ngml1) for
6hours markedly increased both IL-6
transcription and protein secretion. Co-
administration of GMG-43AC prevented
the above effects at the mRNA (Figure 2a
and b) and protein levels (Figure 2c and
d). Notably, no significant change in the
mRNA expression or the secreted amount
of IL-6 was seen following treatment with
GMG-43AC (Figure 2). Although the anti-
inflammatory mechanisms of GMG-43AC
remain to be identified, its parent com-
pound, GED-0507-34L, mediates its anti-
inflammatory effects, at least in part, by
trans-repression of NF-kB signaling
(Mastrofrancesco et al., 2013).
The current pilot study shows that
PPARg activation via GMG-43AC
(Supplementary Figure S1 online) repre-
sents an interesting hair growth–
inhibitory strategy that constitutes a
substantial advancement over currently
practiced therapies for managing un-
desired hair growth: we showed that
stimulating PPARg signaling can effec-
tively abrogate hair growth by premature
catagen induction while protecting
human HF epithelial stem cells. The latter
appears important to maintain the HF
Hair cycle score
*
300
200
100
0
Ve
hic
le
0.0
1 m
M
0.1
 m
M
1 m
M
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
Vehicle
Ve
hic
le
0.0
1 m
M
0.1
 m
M
1 m
M
Anagen Early catagen Mid catagen
K15
K19
Intensity
Intensity Relative number
***
***
**
In
te
ns
ity
Relative number
5010
8
6
4
2
0
6 Days treatment
Ve
hic
le
0.0
1 m
M
0.1
 m
M
1 m
M
6 Days treatment
40
30
20
10
0K1
5-
po
sit
ive
 c
el
ls 
(%
)
Late catagen
0.01 mM 0.1 mM 1 mM
In
te
ns
ity
10
8 ***
***
* *
*** 50
40
30
20
10
0K1
9-
po
sit
ive
 c
el
ls 
(%
)
6
4
2
0
Ve
hic
le
0.0
1 m
M
0.1
 m
M
1 m
M
6 Days treatment
Ve
hic
le
0.0
1 m
M
0.1
 m
M
1 m
M
6 Days treatment
Vehicle
0.1 mM 1 mM
0.01 mM
K15
K19
Vehicle
0.1 mM 1 mM
0.01 mM
Anagen–catagen distribution
Figure 1. GMG-43AC enhances premature catagen, but stimulates keratins K15 and K19. (a) The percentage of hair follicles (HFs) in anagen and early, mid, or
late catagen. GMG43-AC administration induced catagen. (b) Hair cycle score, determined as previously described (Supplementary Reference S2 online).
A higher score means catagen induction. Columns represent means±SEM; data were pooled from five independent experiments (n¼ 54–71 HFs for each group).
(c, d) GMG43-AC stimulated immunoreactivity of K15 (c) and K19 (d) in organ-cultured human scalp HFs. Staining intensities were measured in defined reference
areas (white rectangles) using ImageJ software. In addition, the number of K15- (c) and K19-positive (d) cells was counted relative to the total number of
DAPI-positive cells. Bars¼ 50mm. Columns represent means±SEM (n¼ 22–44 HFs per group). *Po0.05, **Po0.01, ***Po0.001; unpaired two-tailed Student’s
t-test.
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and its stem cells as a regeneration
resource for optimal skin wound healing
(Plikus et al., 2012, Supplementary
Reference S14 online). Therefore, if
applied together with standard depilatory
therapies, PPARg modulators such as
GMG-43AC may allow the optimization
of human hair growth inhibition by
combining catagen induction with stem
cell preservation and anti-inflammatory
properties, thus reducing the pro-
inflammatory sequelae of depilation.
Together with its favorable toxicity
profile (Pirat et al., 2012), this renders
topically applied GMG-43AC an
interesting anti-hirsutism candidate.
PPARg modulators such as GMG-43AC
may also be therapeutically useful in
cicatricial alopecia such as LPP. Here,
LPP progression based on irreversible,
inflammation-induced HF stem cell
damage (Karnik et al., 2009; Harries
et al., 2013) may be inhibited by this
anti-inflammatory and stem cell–protective
PPARg modulator.
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Figure 2. Suppression of IL-6 in response to GMG-43AC. (a, b) The mRNA transcript level of IL-6 evaluated by real-time PCR in normal human keratinocytes
(NHKs) stimulated with IFNg (30 ng ml1) and tumor necrosis factor (TNF-a; 10 ng ml1) in the presence of GMG-43AC (0.5 mM) for 6 hours. The values
are normalized to GAPDH and are expressed relative to those of untreated cells. (c, d) IL-6 protein level measured by ELISA assay in NHK supernatants treated
with IFNg (30ng ml 1) and TNF-a (10 ng ml1) in the presence of GMG-43AC (0.5 mM) for 24 hours. Cytokine levels were measured in duplicate for each
condition and expressed as pg per mg protein. The statistical significance between groups was assessed using paired Student’s t-test **Po0.01; ***Po0.001
versus Ctr; ##Po0.01 versus stimulus.
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TO THE EDITOR
Senescence is a state wherein cells are
metabolically active but are unable to
replicate due to the increased expres-
sion of cell cycle check point proteins,
such as p16INK4A, that prevent passage
of cells through the cycle. p16INK4A
expression increases significantly in the
basal layer of human epidermis and in
dermal fibroblasts, making it a reliable
in vivo biomarker of cellular aging in
human skin (Krishnamurthy et al., 2004;
Ressler et al., 2006; Waaijer et al.,
2012). Moreover, p16INK4A has contin-
ued to gain strong support as an
important component of the aging
process (Sharpless, 2004; Campisi and
d’Adda di Fagagna, 2007; Baker et al.,
2011).
Using in vitro living skin equivalent
(LSE) models constructed in-house (Aho
et al., 2012) with epidermal keratino-
cytes (HEKs) from photo-protected
sites of different age human donors,
and a single neonatal fibroblast donor
(Supplementary Information online), we
demonstrate that the age of the kerati-
nocyte donor differentially impacts the
model’s phenotype. Additionally, we
have notably demonstrated that it is
possible to develop an atrophic, aged
model made from young (30–40 years)
donor HEKs and to revert aged (53–66
years) donor HEK LSEs to a younger
phenotype, by modulating the level of
p16INK4A expression.
Similar to in vivo, we confirmed that
the level of p16INK4A in the aged
model increases in the basal cell layer
and in the lower epidermis, supporting
its usefulness as a biomarker for the
aging phenotype. HEKs from two young
donors formed normal stratified epider-
mis with a well-organized basal layer,
distinct cell layers, and a normal pattern
of differentiation (Figure 1a, left).
Models using five different aged donor
HEKs displayed an unorganized basal
cell layer, fewer spinous and granular
layers, and impaired differentiation,
as reflected by decreased filaggrin
immunostaining (Figure 1a, right). In
this model, substantially fewer Ki-67
positive–stained cells were seen in the
basal layer. This decrease is in agree-
ment with the observations of Gilhar
et al. (2004) in skin biopsies; however,
others have seen either an increase
(Giangreco et al., 2010) or no change
(Ressler et al., 2006) in Ki-67 staining
with age in vivo. This may be due to
variations between donors or due to
in vitro to in vivo differences.
We compared p16INK4A expression
in LSEs made from young and aged
donor cells by immunohistochemistry
(IHC) and immunoblot, and the micro-
graphs shown are representative of the
donor strains tested. In the young donor
LSEs, light staining of p16INK4A was
observed throughout the epidermis
and at a later time point, staining was
specifically localized to the basal layer.
In these samples, p16INK4A was barely
detectable by immunoblot (Figure 1b
and c). Conversely, we saw higher
p16INK4A expression in the aged LSEs
from an early time point and throughout
the experiment. Strong staining was
identified within the basal cell layer
and in the lower stratum spinosum by
IHC, substantiated by increased protein
detected by immunoblot. This increase
in p16INK4A appears to be inversely
correlated with the decrease seen in
markers of proliferation and differentia-
tion, as first observed by Ressler et al.
(2006).
Next, we altered the expression of
p16INK4A in LSEs produced from young
donor HEKs by lentiviral expression of
p16INK4A, driven by a truncatedAccepted article preview online 11 November 2013; published online 12 December 2013
Abbreviations: HEK, human epidermal keratinocyte; IHC, immunohistochemistry; K14, keratin 14;
LSE, living skin equivalent
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